Structure-function relationship of the mammarenavirus envelope glycoprotein
- PMID: 27562602
- PMCID: PMC8193374
- DOI: 10.1007/s12250-016-3815-4
Structure-function relationship of the mammarenavirus envelope glycoprotein
Abstract
Mammarenaviruses, including lethal pathogens such as Lassa virus and Junín virus, can cause severe hemorrhagic fever in humans. Entry is a key step for virus infection, which starts with binding of the envelope glycoprotein (GP) to receptors on target cells and subsequent fusion of the virus with target cell membranes. The GP precursor is synthesized as a polypeptide, and maturation occurs by two cleavage events, yielding a tripartite GP complex (GPC) formed by a stable signal peptide (SSP), GP1 and GP2. The unique retained SSP interacts with GP2 and plays essential roles in virion maturation and infectivity. GP1 is responsible for binding to the cell receptor, and GP2 is a class I fusion protein. The native structure of the tripartite GPC is unknown. GPC is critical for the receptor binding, membrane fusion and neutralization antibody recognition. Elucidating the molecular mechanisms underlining the structure-function relationship of the three subunits is the key for understanding their function and can facilitate novel avenues for combating virus infections. This review summarizes the basic aspects and recent research of the structure-function relationship of the three subunits. We discuss the structural basis of the receptor-binding domain in GP1, the interaction between SSP and GP2 and its role in virion maturation and membrane fusion, as well as the mechanism by which glycosylation stabilizes the GPC structure and facilitates immune evasion. Understanding the molecular mechanisms involved in these aspects will contribute to the development of novel vaccines and treatment strategies against mammarenaviruses infection.
Keywords: Mammarenaviruses; glycoprotein complex (GPC); glycosylation; membrane fusion; stable signal peptide (SSP).
Similar articles
-
Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).J Virol. 2019 Oct 29;93(22):e01277-19. doi: 10.1128/JVI.01277-19. Print 2019 Nov 15. J Virol. 2019. PMID: 31462569 Free PMC article.
-
Small-Molecule Fusion Inhibitors Bind the pH-Sensing Stable Signal Peptide-GP2 Subunit Interface of the Lassa Virus Envelope Glycoprotein.J Virol. 2016 Jul 11;90(15):6799-807. doi: 10.1128/JVI.00597-16. Print 2016 Aug 1. J Virol. 2016. PMID: 27194767 Free PMC article.
-
Characterization of the Glycoprotein Stable Signal Peptide in Mediating Pichinde Virus Replication and Virulence.J Virol. 2016 Oct 28;90(22):10390-10397. doi: 10.1128/JVI.01154-16. Print 2016 Nov 15. J Virol. 2016. PMID: 27630230 Free PMC article.
-
The curious case of arenavirus entry, and its inhibition.Viruses. 2012 Jan;4(1):83-101. doi: 10.3390/v4010083. Epub 2012 Jan 13. Viruses. 2012. PMID: 22355453 Free PMC article. Review.
-
Envelope glycoprotein of arenaviruses.Viruses. 2012 Oct 17;4(10):2162-81. doi: 10.3390/v4102162. Viruses. 2012. PMID: 23202458 Free PMC article. Review.
Cited by
-
Structure-activity relationship optimization for lassa virus fusion inhibitors targeting the transmembrane domain of GP2.Protein Cell. 2019 Feb;10(2):137-142. doi: 10.1007/s13238-018-0604-x. Protein Cell. 2019. PMID: 30632089 Free PMC article. No abstract available.
-
Differences in Glycoprotein Complex Receptor Binding Site Accessibility Prompt Poor Cross-Reactivity of Neutralizing Antibodies between Closely Related Arenaviruses.J Virol. 2017 Mar 13;91(7):e01454-16. doi: 10.1128/JVI.01454-16. Print 2017 Apr 1. J Virol. 2017. PMID: 28100617 Free PMC article.
-
Lassa virus glycoprotein complex review: insights into its unique fusion machinery.Biosci Rep. 2022 Feb 25;42(2):BSR20211930. doi: 10.1042/BSR20211930. Biosci Rep. 2022. PMID: 35088070 Free PMC article. Review.
-
Screening and Identification of Lassa Virus Entry Inhibitors from an FDA-Approved Drug Library.J Virol. 2018 Jul 31;92(16):e00954-18. doi: 10.1128/JVI.00954-18. Print 2018 Aug 15. J Virol. 2018. PMID: 29899092 Free PMC article.
-
Development of horse neutralizing immunoglobulin and immunoglobulin fragments against Junín virus.Antiviral Res. 2020 Feb;174:104666. doi: 10.1016/j.antiviral.2019.104666. Epub 2019 Nov 21. Antiviral Res. 2020. PMID: 31760108 Free PMC article.
References
-
- Abraham J, Kwong JA, Albarino CG, Lu JG, Radoshitzky SR, Salazar-Bravo J, Farzan M, Spiropoulou CF, Choe H. Hostspecies transferrin receptor 1 orthologs are cellular receptors for nonpathogenic new world clade B arenaviruses. PLoS Pathog. 2009;5:e1000358. doi: 10.1371/journal.ppat.1000358. - DOI - PMC - PubMed
-
- Albarino CG, Bird BH, Chakrabarti AK, Dodd KA, Flint M, Bergeron E, White DM, Nichol ST. The major determinant of attenuation in mice of the Candid1 vaccine for Argentine hemorrhagic fever is located in the G2 glycoprotein transmembrane domain. J Virol. 2011;85:10404–10408. doi: 10.1128/JVI.00856-11. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources